A Microassay for the detection of low levels of cytochrome P450 O-deethylation activities with alkoxyresorufin substrates

被引:0
|
作者
Jean Lagueux
Denis Nadeau
Pierre Ayotte
Éric Dewailly
Guy G. Poirier
机构
[1] Centre Hospitalier Universitaire de Québec Research Center,Health and Environment Unit
[2] Centre de Santé publique de Québec,undefined
来源
关键词
CYP-P450; placenta; human; microassay; fluorometry; environmental exposure;
D O I
暂无
中图分类号
学科分类号
摘要
A microfluorometric method for the detection of low levels of cytochrome P450 was developed to increase the sensitivity of the assay, since a low level of CYP450 associated enzymatic activities was expected in human placenta tissues and small samples of placenta (∼10 g) could be easily collected, stored and processed. The dual fluorescence assay of Kennedy et al. [1], which was developed to simultaneously quantitate microsomal proteins and ethoxyresorufin-O-deethylase (EROD) activity was adapted for 96 wells microtiter plates. Placental microsomes samples were analyzed. For samples obtained from non-smoking mothers from the general southern Quebec population, results ranged from less than 1–3.3 pmol/mg protein•min. Samples collected from smoking mothers showed activity levels ranging from 30–69 pmol/mg protein•min. These results showed the suitability of the microassay for measuring low level of CYP450 activity in tissues such as placenta. (Mol Cell Biochem 175: 131–136, 1997)
引用
收藏
页码:125 / 129
页数:4
相关论文
共 50 条
  • [41] Molecular requirements for inhibition of cytochrome P450 activities by roquefortine
    Aninat, C
    Hayashi, Y
    André, F
    Delaforge, M
    CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (09) : 1259 - 1265
  • [42] KINETIC ISOTOPE EFFECT IN THE O-DEETHYLATION OF 7-ETHOXYCOUMARIN BY PURIFIED CYTOCHROMES-P450 AND CYTOCHROMES-P448
    MIWA, GT
    WEST, SB
    LU, AYH
    FEDERATION PROCEEDINGS, 1980, 39 (03) : 611 - 611
  • [43] Substrates of human hepatic cytochrome P450 3A4
    Li, AP
    Kaminski, DL
    Rasmussen, A
    TOXICOLOGY, 1995, 104 (1-3) : 1 - 8
  • [44] OVERLAP BETWEEN DRUG AND ENDOGENOUS SUBSTRATES OF CYTOCHROME P450 ENZYMES
    Guengerich, F. Peter
    DRUG METABOLISM REVIEWS, 2015, 47 : 23 - 23
  • [45] Comparison of Drosophila cytochrome P450 metabolism of natural and model substrates
    Frank, MR
    Danielson, PB
    Fogleman, JC
    JOURNAL OF INSECT PHYSIOLOGY, 1997, 43 (10) : 953 - 957
  • [46] Nanotechnology approaches for delivery of cytochrome P450 substrates in HIV treatment
    Gong, Yuqing
    Chowdhury, Pallabita
    Nagesh, Prashanth K. B.
    Cory, Theodore J.
    Dezfuli, Chelsea
    Kodidela, Sunitha
    Singh, Ajay
    Yallapu, Murali M.
    Kumar, Santosh
    EXPERT OPINION ON DRUG DELIVERY, 2019, 16 (08) : 869 - 882
  • [47] Synthesis and testing of a library of fluorescein diether cytochrome P450 substrates
    Cloyd, Ryan A.
    McCauley, Austin M.
    Wysocki, Laura M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [48] Prevalence and implications of cytochrome P450 substrates in Massachusetts hospital discharges
    T H McCoy
    V M Castro
    A Cagan
    A M Roberson
    R H Perlis
    The Pharmacogenomics Journal, 2017, 17 : 382 - 385
  • [49] Prevalence and implications of cytochrome P450 substrates in Massachusetts hospital discharges
    Mccoy, T. H.
    Castro, V. M.
    Cagan, A.
    Roberson, A. M.
    Perlis, R. H.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (04): : 382 - 385
  • [50] CYTOCHROME-P450 SPECIFICITIES OF ALKOXYRESORUFIN O-DEALKYLATION IN HUMAN AND RAT-LIVER
    BURKE, MD
    THOMPSON, S
    WEAVER, RJ
    WOLF, CR
    MAYER, RT
    BIOCHEMICAL PHARMACOLOGY, 1994, 48 (05) : 923 - 936